Please assess the completion status of the following clinical trial:

Trial Title: WP02 Continued Access Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is 18 years of age or greater~* Subject is registered as an active recipient on the UNOS waiting list for liver transplantation~* Subject, or legally authorized representative, is able and willing to give informed consent and HIPAA authorization~* Subject is able and willing to comply with all study requirements~Exclusion Criteria:~* Subject requiring all of the following at the time of transplantation:~  1. Oxygen therapy via a ventilator/respirator~ 2. Inotropic support~ 3. Renal replacement therapy~* Subject has acute/fulminant liver failure (UNOS status 1A)~* Subject undergoing simultaneous transplantation of more than one organ (e.g., liver and kidney)~* Subject is pregnant (as confirmed by urine or serum pregnancy test) or nursing~* Concurrent enrollment in another clinical trial. Subjects enrolled in clinical trials or registries where only measurements and/or samples are taken (NO TEST DEVICE or TEST DRUG USED) are allowed to participate.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Normothermic Machine Perfusion (NMP) (Type: EXPERIMENTAL): Following the routine retrieval procedure of the liver, it will be placed on the OrganOx metra for Normothermic Machine Perfusion (NMP) for transport per the Investigational Plan and the Instructions for Use.

Based on this trial design, predict the completion outcome and termination type (if applicable).